Company: SNY
Filing Date: 2025-10-27
Form Type: 424B5
Source: 0001193125-25-250786
Chunk: 64

Company: Sanofi
Filing Date: 2025-10-27
Form: 424B5
Chunk 64
---
ally represents, warrants and agrees that it and its respective affiliates and any other person acting on its or their behalf has or have not offered or sold and will not S-46

offer or sell, directly or indirectly, the notes to the public in France, and has or have not released, issued, distributed or caused to be released, issued or distributed to the public in France
or used in connection with any offer for subscription or sale of the notes, the prospectus or any other offering material relating to the notes, and that such offers, sales and distributions have been and will be made in France only to qualified
investors (investisseurs qualifiés) as defined in the Prospectus Regulation or to fewer than 150 natural or legal persons (other than qualified investors as defined in the Prospectus Regulation) other than individuals, in each case
investing for their own account and as provided in Articles L. 411-2, and R. 711-4 to R. 711-6 of the French Code monétaire et financier.

United Kingdom

The notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to
any retail investor in the United Kingdom (“UK”). For these purposes, a “retail investor” means a person who is one (or more) of the following: (i) a retail client as defined in point (8) of Article 2 of Regulation
(EU) 2017/565 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (“EUWA”) (“UK MIFIR”); or (ii) a customer, within the meaning of the provisions of the FSMA and any rules or
regulations made under the Financial Services and Markets Act 2000 (“FSMA”) to implement Directive (EU) 2016/97, where that customer would not qualify as a professional client.

Consequently, no key information document required by Regulation (EU) 1286/2014 as it forms part of domestic law by virtue of the EUWA (the
“UK PRIIPs Regulation”) for offering or selling the notes or otherwise making them available to retail investors in the UK has been prepared and therefore offering or selling the notes or otherwise making them available to any retail
investor in the UK may be unlawful under the UK PRIIPs Regulation. Any offer of notes in the UK will only be made pursuant to an exemption under